2024 BRFSS Survey Results: North Carolina

Prostate Cancer Screening (Males, Age 40+)

A Prostate-Specific Antigen test, also called a PSA test, is a blood test used to check men for prostate cancer.

Has a doctor, nurse, or other health professional EVER talked with you about the Advantages, Disadvantages or Both of the PSA test?*

View results for a demographic group:
 Select a different topic:
View results for a different geographical area:
  Total
Respond.^		 Advantages Disdvantages Both Advantages and Disadvantages Neither
N % C.I.(95%) N % C.I.(95%) N % C.I.(95%) N % C.I.(95%)
TOTAL 830 66 8.2 6.1-10.9 2 0.1 0.0- 0.5 299 34.4 30.7-38.2 463 57.3 53.3-61.2

Back to Prostate Cancer Screening (Males, Age 40+).

*This question was asked of those who reported having a PSA test.

PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2024
are NOT comparable to 2010 and earlier years.

Sub-group estimates have been suppressed because they do not meet statistical reliability standards.

^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.

BRFSS Home | Annual Questionnaires | Technical Notes

This page was generated on 18SEP25.

SCHS Home | FAQs | Contacts